SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Soligenix Announces Third-Quarter 2026 Financial Results and Updates

Soligenix announced its third-quarter 2026 financial results and recent updates.

SNGX

PRINCETON, N.J., Nov. 6, 2026 // -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today its recent updates and financial resul…

Related stories